Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENA-TIA: 10 vs 30 Days DAPT in Acute TIA
NCT02144831Phase 4Withdrawn
- Sponsor
- University of Alberta
- Start
- Jul 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in Transient Ischemic Attack (TIA), ischemic stroke, sponsored by University of Alberta. Planned start Jul 2014; status: withdrawn.
02
Drugs
clopidogrel
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT02144831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144831.